Alice Laudisio1, Stefania Bandinelli2, Antonella Gemma3, Luigi Ferrucci4, Raffaele Antonelli Incalzi5. 1. Area di Geriatria, Campus Bio-Medico University, Via Álvaro del Portillo, 200, 00128 Rome, Italy. Electronic address: lavoralice@gmail.com. 2. Geriatric Rehabilitation Unit, Azienda Sanitaria di Firenze, Florence, Italy. 3. UOS Accesso e Presa in Carico Assistenziale, Azienda Sanitaria Locale Roma E, Rome, Italy. 4. Longitudinal Studies Section, Clinical Research Branch, National Institute on Aging, Baltimore, MD, USA. 5. Area di Geriatria, Campus Bio-Medico University, Via Álvaro del Portillo, 200, 00128 Rome, Italy.
Abstract
BACKGROUND & AIMS: Metabolic syndrome (MetS) is associated with incident disability in middle-aged subjects. We evaluated the association of MetS with functional ability in an older population. METHODS: We enrolled 1155 participants aged 65+, derived from the InCHIANTI study, and followed for 3 years. MetS was diagnosed according to the National Cholesterol Education Program's ATP-III criteria. Functional ability was estimated using the Katz's activities of daily living (ADLs), and the Lawton and Brody for the instrumental activities of daily living (IADLs) scales. The association between disability and MetS at baseline and after follow-up was assessed by logistic regression. RESULTS: At baseline, MetS was associated with reduced probability of ADLs disability among participants aged 74+ (OR = .33, 95% CI = .14-.77; p = .010), but not in younger (5.08, 95% CI = .88-29.24; p = .069). Also, MetS was associated with reduced probability of incident ADLs disability (OR = .61, 95% CI .41-.91; p = .016), but neither with prevalent, nor incident IADLs disability. CONCLUSIONS: In older persons, MetS is associated with reduced probability of prevalent and incident ADLs disability. Whether older persons with MetS should receive treatment and whether the current diagnostic criteria for MetS apply to older individuals need further investigation.
BACKGROUND & AIMS:Metabolic syndrome (MetS) is associated with incident disability in middle-aged subjects. We evaluated the association of MetS with functional ability in an older population. METHODS: We enrolled 1155 participants aged 65+, derived from the InCHIANTI study, and followed for 3 years. MetS was diagnosed according to the National Cholesterol Education Program's ATP-III criteria. Functional ability was estimated using the Katz's activities of daily living (ADLs), and the Lawton and Brody for the instrumental activities of daily living (IADLs) scales. The association between disability and MetS at baseline and after follow-up was assessed by logistic regression. RESULTS: At baseline, MetS was associated with reduced probability of ADLs disability among participants aged 74+ (OR = .33, 95% CI = .14-.77; p = .010), but not in younger (5.08, 95% CI = .88-29.24; p = .069). Also, MetS was associated with reduced probability of incident ADLs disability (OR = .61, 95% CI .41-.91; p = .016), but neither with prevalent, nor incident IADLs disability. CONCLUSIONS: In older persons, MetS is associated with reduced probability of prevalent and incident ADLs disability. Whether older persons with MetS should receive treatment and whether the current diagnostic criteria for MetS apply to older individuals need further investigation.
Authors: Giovanni Ravaglia; Paola Forti; Fabiola Maioli; Luciana Bastagli; Martina Chiappelli; Fausta Montesi; Luigi Bolondi; Christopher Patterson Journal: Diabetes Care Date: 2006-11 Impact factor: 19.112
Authors: P Ferrari; N Slimani; A Ciampi; A Trichopoulou; A Naska; C Lauria; F Veglia; H B Bueno-de-Mesquita; M C Ocké; M Brustad; T Braaten; M José Tormo; P Amiano; I Mattisson; G Johansson; A Welch; G Davey; K Overvad; A Tjønneland; F Clavel-Chapelon; A Thiebaut; J Linseisen; H Boeing; B Hemon; E Riboli Journal: Public Health Nutr Date: 2002-12 Impact factor: 4.022
Authors: Tasnime N Akbaraly; Archana Singh-Manoux; Adam G Tabak; Markus Jokela; Marianna Virtanen; Jane E Ferrie; Michael G Marmot; Martin J Shipley; Mika Kivimaki Journal: Diabetes Care Date: 2010-07-29 Impact factor: 19.112
Authors: Anda Botoseneanu; Walter T Ambrosius; Daniel P Beavers; Nathalie de Rekeneire; Stephen Anton; Timothy Church; Sara C Folta; Bret H Goodpaster; Abby C King; Barbara J Nicklas; Bonnie Spring; Xuewen Wang; Thomas M Gill Journal: J Am Geriatr Soc Date: 2015-01-30 Impact factor: 5.562
Authors: Anda Botoseneanu; Haiying Chen; Walter T Ambrosius; Heather G Allore; Stephen Anton; Sara C Folta; Abby C King; Barbara J Nicklas; Bonnie Spring; Elsa S Strotmeyer; Thomas M Gill Journal: Exp Gerontol Date: 2021-04-10 Impact factor: 4.032
Authors: Jenna M Napoleone; Robert M Boudreau; Brittney S Lange-Maia; Samar R El Khoudary; Kelly R Ylitalo; Andrea M Kriska; Carrie A Karvonen-Gutierrez; Elsa S Strotmeyer Journal: J Gerontol A Biol Sci Med Sci Date: 2022-02-03 Impact factor: 6.591
Authors: Jeanine M Van Ancum; Nini H Jonkman; Natasja M van Schoor; Emily Tressel; Carel G M Meskers; Mirjam Pijnappels; Andrea B Maier Journal: PLoS One Date: 2018-10-31 Impact factor: 3.240